Sarah-Matio E. M., Guillochon E., Nsango S. E., Abate Luc, Ngou C. M., Bouopda G. A., Feufack-Donfack L. B., Bayibeki A. N., Tsapi M. T., Talman Arthur, Marin-Menendez A., Ayong L., Claessens A., Lefèvre Thierry, Berry A., Morlais Isabelle. (2022). Genetic diversity of Plasmodium falciparum and distribution of antimalarial drug resistance mutations in symptomatic and asymptomatic infections. Antimicrobial Agents and Chemotherapy, [Early access], p. 00188-22 [11 p.]. ISSN 0066-4804.
Titre du document
Genetic diversity of Plasmodium falciparum and distribution of antimalarial drug resistance mutations in symptomatic and asymptomatic infections
Année de publication
2022
Auteurs
Sarah-Matio E. M., Guillochon E., Nsango S. E., Abate Luc, Ngou C. M., Bouopda G. A., Feufack-Donfack L. B., Bayibeki A. N., Tsapi M. T., Talman Arthur, Marin-Menendez A., Ayong L., Claessens A., Lefèvre Thierry, Berry A., Morlais Isabelle
Source
Antimicrobial Agents and Chemotherapy, 2022,
[Early access], p. 00188-22 [11 p.] ISSN 0066-4804
Malaria control relies on passive case detection, and this strategy fails detecting asymptomatic infections. In addition, infections in endemic areas harbor multiple parasite genotypes that could affect case management and malaria epidemiology. Here, we performed AmpSeq genotyping to capture polymorphisms associated with antimalarial resistance and the genetic diversity within natural Plasmodium falciparum infections. Known genetic polymorphisms associated with altered drug susceptibility were screened for the five most common marker genes, pfdhfr, pfdhps, pfmdr1, pfcrt, and pfK13, and genetic diversity was established from two known AmpSeq markers, cpmp and csp. Relative abundance of the different genotypes within mixed infections was calculated from the number of reads per genotype. Genotyping was performed on 117 samples, 63 from asymptomatic and 54 from symptomatic individuals. We identified up to 15 genotypes within an infection, and the median multiplicity of infection was higher in asymptomatic infections (median MOI = 5 in asymptomatics versus median MOI = 2 in symptomatics, P < 0.001). No genetic differentiation on parasites from asymptomatic and symptomatic individuals was found. No mutation associated with ART resistance was identified. Prevalence of the P. falciparum chloroquine resistance wild-type genotype (CVMNK) reached 80%, confirming a return to chloroquine (CQ) sensitive parasites in Cameroon. In addition, the CQ-associated resistant genotype (CVIET) was present at very low density in polyclonal infections. Persistence of low-density chloroquine resistant parasites indicates competition-survival trade-offs may contribute to maintaining genetic diversity in natura. Thus, monitoring the expansion of these low-density genotypes in different immune backgrounds will be critical to evaluate drug policy changes.
Plan de classement
Santé : généralités [050]
;
Entomologie médicale / Parasitologie / Virologie [052]
Description Géographique
CAMEROUN
Localisation
Fonds IRD [F B010085418]
Identifiant IRD
fdi:010085418
